We also recently showed that XCR1, an established cDC1 marker, and its T cell-derived ligands XCL1 and XCL2, are all specifically differentially overexpressed in muscle of IBM patients compared to that of patients with other inflammatory myopathies10. The gene discussed is MPPE1; the disease is inclusion body myositis.